Clinical trial
Reducing Hospital Admission of Elderly in SARS-CoV-2 Pandemic Via the Induction of Trained Immunity by Bacillus Calmette-Guérin Vaccination, a Randomized Controlled Trial
NCT04417335 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reducing Hospital Admission of Elderly in SARS-CoV-2 Pandemic Via the Induction of Trained Immunity by Bacillus Calmette-Guérin Vaccination, a Randomized Controlled Trial
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 16, 2020
- Completion date
- May 31, 2021
- Enrollment
- 2,014 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.